Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVS SR vs Escitalopram in Postmenopausal Women with MDD
NCT00406640Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Dec 2006; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00406640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406640.